Elevated Notch1 enhances interleukin-22 production by CD4+ T cells via aryl hydrocarbon receptor in patients with lung adenocarcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated Notch1 enhances interleukin-22 production by CD4+ T cells via aryl hydrocarbon receptor in patients with lung adenocarcinoma
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 38, Issue 6, Pages BSR20181922
Publisher
Portland Press Ltd.
Online
2018-11-26
DOI
10.1042/bsr20181922
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies
- (2018) Sun Min Lim et al. CANCER TREATMENT REVIEWS
- A catch-22: Interleukin-22 and cancer
- (2018) Pedro Hernandez et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes
- (2018) Zheng Yang et al. International Journal of Biological Sciences
- Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints
- (2018) Tao Shi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Third generation EGFR TKIs: current data and future directions
- (2018) Chee-Seng Tan et al. Molecular Cancer
- Combination Immunotherapy in Non-small Cell Lung Cancer
- (2018) Melina E. Marmarelis et al. Current Oncology Reports
- Targeting interleukin-22 for cancer therapy
- (2018) Anamarija Markota et al. Human Vaccines & Immunotherapeutics
- Liquid biopsy for lung cancer early detection
- (2018) Mariacarmela Santarpia et al. Journal of Thoracic Disease
- Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
- (2018) Young Kwang Chae et al. Journal for ImmunoTherapy of Cancer
- Notch Signaling in the Tumor Microenvironment
- (2018) Olivier Meurette et al. CANCER CELL
- Notch signaling pathway suppresses CD8+ T cells activity in patients with lung adenocarcinoma
- (2018) Shuo Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
- (2018) Venus Sosa Iglesias et al. Frontiers in Oncology
- Cancer cells induce interleukin-22 production from memory CD4+T cells via interleukin-1 to promote tumor growth
- (2017) Cornelia Voigt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Notch Signaling Regulates Circulating T Helper 22 Cells in Patients with Chronic Hepatitis C
- (2017) Ben-Chun Jiang et al. VIRAL IMMUNOLOGY
- Dual roles of IL-22 at ischemia-reperfusion injury and acute rejection stages of rat allograft liver transplantation
- (2017) Yi Zhang et al. Oncotarget
- Notch signaling triggers the tumor heterogeneity of small cell lung cancer
- (2017) Lydia Meder et al. Journal of Thoracic Disease
- Histone Modifications of Notch1 Promoter Affect Lung CD4+ T Cell Differentiation in Asthmatic Rats
- (2017) Z-L. Cui et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases
- (2016) Amanda Tufman et al. BMC CANCER
- Interleukin-22 promotes lung cancer cell proliferation and migration via the IL-22R1/STAT3 and IL-22R1/AKT signaling pathways
- (2016) Yi Bi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Notch Signaling Contributes to Liver Inflammation by Regulation of Interleukin-22-Producing Cells in Hepatitis B Virus Infection
- (2016) Xin Wei et al. Frontiers in Cellular and Infection Microbiology
- Interleukin-22: Immunobiology and Pathology
- (2015) Jarrod A. Dudakov et al. Annual Review of Immunology
- Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitors
- (2015) Mariacarmela Santarpia et al. Future Oncology
- Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
- (2014) Xun Yuan et al. Journal of Hematology & Oncology
- Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells
- (2013) Sebastian Kobold et al. Journal of Thoracic Oncology
- Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation
- (2011) Ying Li et al. CELL
- STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers
- (2011) Teppei Morikawa et al. CLINICAL CANCER RESEARCH
- A Proinflammatory Role for Interleukin-22 in the Immune Response to Hepatitis B Virus
- (2011) Ye Zhang et al. GASTROENTEROLOGY
- Notch signaling is necessary for adult, but not fetal, development of RORγt+ innate lymphoid cells
- (2011) Cécilie Possot et al. NATURE IMMUNOLOGY
- AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch
- (2011) Jacob S Lee et al. NATURE IMMUNOLOGY
- Natural Aryl Hydrocarbon Receptor Ligands Control Organogenesis of Intestinal Lymphoid Follicles
- (2011) E. A. Kiss et al. SCIENCE
- Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor
- (2010) M. S. Alam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
- (2009) Geethanjali Pickert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Jagged1 on Dendritic Cells and Notch on CD4+ T Cells Initiate Lung Allergic Responsiveness by Inducing IL-4 Production
- (2009) M. Okamoto et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started